Guidance Documents Library

Title Areasort descending
Cobalt - 2019 Cycle 10 DPH
Ebola Contaminated Waste, Handling, Decontamination, Transport, and Disposal in a Non-Health Care Setting DPH
Communicable Disease Case Reporting and Investigation Protocol: Diphtheria DPH
Thiencarbazone-methyl - 2019 Cycle 10 DPH
Reporting of HIV Infection and AIDS in Wisconsin DPH
Changes to COVID-19 Reporting Requirements for Wisconsin Hospitals and Health Departments DPH
Babies & Hearing Loss DPH
Influenza Testing and Variant Influenza A Virus Detection DPH
Laboratory Testing Options for Prion Diseases DPH
Guidance for Licenses of Broad Scope DPH
Tetrachloroterephthalic Acid - 2019 Cycle 10 DPH
Follow-Up for Interferon Gamma Release Assay (IGRA) Reports: Checklist for Public Health Staff DPH
Communicable Disease Case Reporting and Investigation Protocol: Mumps DPH
Perfluorooctanoic acid (PFOA) - 2019 Cycle 10 DPH
Updated guidance for local health departments and government partners about home isolation and quarantine for COVID-19 DPH
Mutual Aid DPH
Prevention and Control of Acute Respiratory Illness Outbreaks in Long-Term Care Facilities DPH
Wisconsin Authorized Infant Formula Suppliers DPH
Guidance For Self -Shielded Irradiators DPH
Monomethyl Tetrachloroterephthalic Acid - 2019 Cycle 10 DPH
Communicable Disease Case Reporting and Investigation Protocol: Measles DPH
What to do if someone breaks quarantine: Guidance for Local Health Departments (LHDs) DPH
Communicable Diseases Funding DPH
Board for Evaluation of Interpreters (BEI): Test of English Proficiency (TEP) DPH
Interfacility Transport Guidelines 2006 DPH
Guidance Related to Viral Whole Genome Sequencing of SARS-CoV-2 for the Public Health Response DPH
Wisconsin Well Woman Program Policy and Procedures Manual DPH
Guidance for Uses of Sealed Sources DPH
Glyphosate - 2019 Cycle 10 DPH
Please do not visit. DPH
Communicable Disease Case Reporting and Investigation Protocol: Poliovirus Infection DPH
Nurse Case Management for Active Tuberculosis (TB) Disease DPH
Information for Dental Health Care Professionals (DHCP): What You Need to Know about Coronavirus Disease (COVID-19) DPH
1,2,3-Trichloropropane - 2019 Cycle 10 DPH
First Responders as Members of a Legal Crew DPH
Wisconsin Well Woman Program Income Eligibility Guidelines DPH
Aminomethylphosphonic Acid (AMPA) - 2019 Cycle 10 DPH
How to Give Naloxone DPH
Asbestos Project Notification DPH
Communicable Disease Case Reporting and Investigation Protocol: Pertussis DPH
Important Information for Recipients of Personal Protective Equipment (PPE) from the Strategic National Stockpile (SNS) DPH
Latent Tuberculosis Infection (LTBI) as a Reportable Condition in Wisconsin DPH
Wisconsin Well Woman Program (WWWP) Procedure Code Quick Reference DPH
Using Text Messaging for Communicable Disease Follow-up at Local Health Departments DPH
Imidacloprid - 2019 Cycle 10 DPH
Statewide Naloxone Standing Order for Pharmacist DPH
Coronavirus Disease 2019 (COVID-19) Update: Recommendations on Domestic and International Travel DPH
Communicable Disease Case Reporting and Investigation Protocol: Rubella and Congenital Rubella Syndrome (CRS) DPH
Important Guidance for Infection Prevention and Control of Coronavirus Disease 2019 (COVID-19) (REVISED) in Long-Term Care Facilities and Assisted Living Facilities DPH
Request to Health Care Providers: Hepatitis A Vaccination in Emergency Health Care Settings to Prevent Outbreaks in Wisconsin DPH

Pages

Last Revised: November 23, 2020